[Hypoglycemic sulfamides: new pharmacologic data and practical implications].
Service de Médecine Interne B, Hôpitaux Universitaires, Strasbourg.
J F
JF
Blickle
J M
JM
Brogard
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004357:Drug Synergism; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D010818:Practice Patterns, Physicians'; D012307:Risk Factors; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds